FDA Approves ACETAMINOPHEN AND CODEINE PHOSPHATE — Strides Pharma Science Limited
Strides Pharma Science Limited announced the FDA approval of its ANDA089805 for oral Acetaminophen and Codeine Phosphate, positioning the company to capture market share within the generic analgesic segment.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day